150 related articles for article (PubMed ID: 1946315)
1. Ultrastructural differentiation of sodium butyrate-treated human pancreatic adenocarcinoma cell lines.
Mullins TD; Kern HF; Metzgar RS
Pancreas; 1991 Sep; 6(5):578-87. PubMed ID: 1946315
[TBL] [Abstract][Full Text] [Related]
2. Modification of antigen expression in human and hamster pancreatic cancer cell lines induced by sodium butyrate.
Corra S; Kazakoff K; Mogaki M; Cano M; Pour PM
Teratog Carcinog Mutagen; 1993; 13(5):199-215. PubMed ID: 7905674
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural differentiation and CEA expression of butyrate-treated human pancreatic carcinoma cells.
el-Deriny SE; O'Brien MJ; Christensen TG; Kupchik HZ
Pancreas; 1987; 2(1):25-33. PubMed ID: 3575313
[TBL] [Abstract][Full Text] [Related]
4. Effects of sodium butyrate and dimethylsulfoxide on human pancreatic tumor cell lines.
McIntyre LJ; Kim YS
Eur J Cancer Clin Oncol; 1984 Feb; 20(2):265-71. PubMed ID: 6200329
[TBL] [Abstract][Full Text] [Related]
5. Sodium butyrate induces neuroendocrine cytodifferentiation in the insulinoma cell line RINm5F.
Swarovsky B; Eissele R; Eisenacher M; Trautmann ME; Arnold R
Pancreas; 1994 Jul; 9(4):460-8. PubMed ID: 7937695
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of pancreatic carcinoma induced by retinoic acid or sodium butyrate: a morphological and molecular analysis of four cell lines.
Egawa N; Maillet B; VanDamme B; De Grève J; Klöppel G
Virchows Arch; 1996 Sep; 429(1):59-68. PubMed ID: 8865855
[TBL] [Abstract][Full Text] [Related]
7. Characterization of clones of a human pancreatic adenocarcinoma cell line representing different stages of differentiation.
Kim YW; Kern HF; Mullins TD; Koriwchak MJ; Metzgar RS
Pancreas; 1989; 4(3):353-62. PubMed ID: 2734279
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on membrane-associated antigen, enzymes, and glycoproteins of human rectal adenocarcinoma cells.
Tsao D; Morita A; Bella A; Luu P; Kim YS
Cancer Res; 1982 Mar; 42(3):1052-8. PubMed ID: 7059970
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of sodium butyrate and hyperosmolality on the modulation of alkaline phosphatases of LoVo cells.
Herz F; Halwer M
Exp Cell Res; 1990 May; 188(1):50-4. PubMed ID: 2328777
[TBL] [Abstract][Full Text] [Related]
10. Effects of sodium butyrate on human colonic adenocarcinoma cells. Induction of placental-like alkaline phosphatase.
Gum JR; Kam WK; Byrd JC; Hicks JW; Sleisenger MH; Kim YS
J Biol Chem; 1987 Jan; 262(3):1092-7. PubMed ID: 3805014
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of BCS-TC2 human colon adenocarcinoma cells by sodium butyrate: increase in 5'-nucleotidase activity.
Navarro JM; Olmo N; Turnay J; López-Conejo MT; Lizarbe MA
Eur J Clin Invest; 1997 Jul; 27(7):620-8. PubMed ID: 9263751
[TBL] [Abstract][Full Text] [Related]
12. Emergence of an irreversible differentiated subclone from the poorly differentiated ovarian adenocarcinoma cell line AMOC-2 treated with sodium butyrate.
Yabushita H; Noguchi M; Nakanishi M
J Obstet Gynaecol Res; 1997 Dec; 23(6):493-502. PubMed ID: 9433040
[TBL] [Abstract][Full Text] [Related]
13. Characterization of four clones derived from human adenocarcinoma cell line, HT29, and analysis of their response to sodium butyrate.
Stokrová J; Sloncová E; Sovová V; Kucerová D; Zíla V; Turecková J; Vojtechová M; Korb J; Tuhácková Z
Int J Oncol; 2006 Feb; 28(2):559-65. PubMed ID: 16391813
[TBL] [Abstract][Full Text] [Related]
14. Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines.
Langdon SP; Hawkes MM; Hay FG; Lawrie SS; Schol DJ; Hilgers J; Leonard RC; Smyth JF
Cancer Res; 1988 Nov; 48(21):6161-5. PubMed ID: 3167862
[TBL] [Abstract][Full Text] [Related]
15. Different morphological changes of two colorectal adenocarcinoma cell lines after sodium butyrate treatment.
Stokrová J; Sovová V; Sloncová E; Korb J
Int J Mol Med; 1999 Dec; 4(6):669-74. PubMed ID: 10567682
[TBL] [Abstract][Full Text] [Related]
16. Effect of sodium butyrate on glucose transport and glucose-phosphorylating enzymes in RIN-m5F cells.
Fernandez-Mejia C; Davidson MB
Pancreas; 1993 Sep; 8(5):589-96. PubMed ID: 8302795
[TBL] [Abstract][Full Text] [Related]
17. Effect of sodium butyrate, a differentiating agent, on cell surface glycoconjugates of a human pancreatic cell line.
Bloom EJ; Siddiqui B; Hicks JW; Kim YS
Pancreas; 1989; 4(1):59-64. PubMed ID: 2717602
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of sodium butyrate and dimethylsulfoxide on gamma-glutamyl transpeptidase and alkaline phosphatase activities in MCF-7 breast cancer cells.
Wasserman L; Nordenberg J; Beery E; Deutsch AA; Novogrodsky A
Exp Cell Biol; 1987; 55(4):188-93. PubMed ID: 2890541
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of sodium butyrate and hexamethylene bisacetamide on growth and secretion of cultured human endocrine tumor cells.
Parekh D; Ishizuka J; Townsend CM; Haber BE; Beauchamp RD; Rajaraman S; Karp G; Hsieh J; Thompson JC
Arch Surg; 1991 Apr; 126(4):467-72. PubMed ID: 1706915
[TBL] [Abstract][Full Text] [Related]
20. Effects of sodium butyrate, dimethylsulfoxide and dibutyryl cAMP on the poorly differentiated ovarian adenocarcinoma cell line AMOC-2.
Yabushita H; Sartorelli AC
Oncol Res; 1993; 5(4-5):173-82. PubMed ID: 8305743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
